Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

In this episode, D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, answer questions on investigational antibody-drug conjugates for advanced NSCLC  Presenters:Ross Camidge, MD, PhD  Professor of Medicine/Oncology  University of Colorado Cancer CenterAurora, ColoradoJoel W. Neal, MD, PhD  Associate Professor of MedicineDivision of OncologyDepartment of MedicineStanford UniversityAttending PhysicianStanford Cancer InstitutePalo Alto, CaliforniaContent based on an online IME program supported by educational grants from Daiichi Sankyo, Inc .Link to full program:http://bit.ly/3twpIyl  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.